World Investment Advisors Has $1.57 Million Stake in Cigna Group $CI

World Investment Advisors lowered its position in shares of Cigna Group (NYSE:CI) by 27.4% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 5,698 shares of the health services provider’s stock after selling 2,155 shares during the period. World Investment Advisors’ holdings in Cigna Group were worth $1,568,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also bought and sold shares of CI. Banco Bilbao Vizcaya Argentaria S.A. boosted its position in Cigna Group by 13.5% during the 3rd quarter. Banco Bilbao Vizcaya Argentaria S.A. now owns 34,114 shares of the health services provider’s stock worth $9,839,000 after buying an additional 4,066 shares during the period. Distillate Capital Partners LLC increased its position in Cigna Group by 19.1% in the 3rd quarter. Distillate Capital Partners LLC now owns 108,676 shares of the health services provider’s stock valued at $31,338,000 after acquiring an additional 17,442 shares during the period. Cooperman Leon G raised its stake in shares of Cigna Group by 53.3% during the third quarter. Cooperman Leon G now owns 325,000 shares of the health services provider’s stock valued at $93,681,000 after acquiring an additional 113,000 shares during the last quarter. Schroder Investment Management Group raised its stake in shares of Cigna Group by 53.0% during the third quarter. Schroder Investment Management Group now owns 190,710 shares of the health services provider’s stock valued at $54,972,000 after acquiring an additional 66,090 shares during the last quarter. Finally, apricus wealth LLC lifted its holdings in shares of Cigna Group by 715.9% during the fourth quarter. apricus wealth LLC now owns 9,505 shares of the health services provider’s stock worth $2,616,000 after purchasing an additional 8,340 shares during the period. Institutional investors and hedge funds own 86.99% of the company’s stock.

Analyst Upgrades and Downgrades

A number of analysts recently weighed in on CI shares. Wolfe Research restated an “outperform” rating and issued a $315.00 price objective on shares of Cigna Group in a report on Tuesday. UBS Group lifted their target price on Cigna Group from $375.00 to $400.00 and gave the stock a “buy” rating in a report on Friday, May 22nd. Royal Bank Of Canada increased their price target on Cigna Group from $333.00 to $337.00 and gave the company an “outperform” rating in a research note on Friday, May 1st. Mizuho lifted their price objective on Cigna Group from $330.00 to $340.00 and gave the stock an “outperform” rating in a research note on Monday, June 8th. Finally, Cantor Fitzgerald raised their price target on shares of Cigna Group from $325.00 to $340.00 and gave the stock an “overweight” rating in a report on Friday, May 1st. One investment analyst has rated the stock with a Strong Buy rating, fifteen have issued a Buy rating and six have given a Hold rating to the company. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $338.30.

Cigna Group Stock Up 0.1%

Shares of NYSE:CI opened at $279.63 on Friday. Cigna Group has a 1 year low of $239.51 and a 1 year high of $338.89. The company has a debt-to-equity ratio of 0.69, a current ratio of 0.73 and a quick ratio of 0.73. The business’s 50-day moving average is $283.79 and its 200-day moving average is $278.33. The company has a market capitalization of $73.97 billion, a price-to-earnings ratio of 11.85, a P/E/G ratio of 1.08 and a beta of 0.28.

Cigna Group (NYSE:CI) last released its earnings results on Thursday, April 30th. The health services provider reported $7.79 EPS for the quarter, topping the consensus estimate of $7.60 by $0.19. The business had revenue of $68.52 billion during the quarter, compared to analysts’ expectations of $66.29 billion. Cigna Group had a return on equity of 19.75% and a net margin of 2.26%.The firm’s revenue was up 4.6% on a year-over-year basis. During the same quarter last year, the firm posted $6.74 earnings per share. Cigna Group has set its FY 2026 guidance at 30.350- EPS. Equities research analysts predict that Cigna Group will post 30.39 earnings per share for the current year.

Cigna Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Thursday, June 18th. Stockholders of record on Thursday, June 4th were given a dividend of $1.56 per share. The ex-dividend date of this dividend was Thursday, June 4th. This represents a $6.24 annualized dividend and a dividend yield of 2.2%. Cigna Group’s dividend payout ratio (DPR) is 26.45%.

Insider Buying and Selling at Cigna Group

In other Cigna Group news, CAO Jamie G. Kates sold 899 shares of the firm’s stock in a transaction on Friday, June 12th. The shares were sold at an average price of $298.61, for a total value of $268,450.39. Following the completion of the sale, the chief accounting officer directly owned 2,368 shares in the company, valued at approximately $707,108.48. This trade represents a 27.52% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CEO David Cordani sold 201,878 shares of the firm’s stock in a transaction on Tuesday, May 12th. The stock was sold at an average price of $292.82, for a total transaction of $59,113,915.96. Following the completion of the sale, the chief executive officer owned 34,337 shares of the company’s stock, valued at $10,054,560.34. The trade was a 85.46% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders own 0.60% of the company’s stock.

About Cigna Group

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.